Educational Testing Service Offers Employees Free Prostate Cancer Screening Through Fox Chase Cancer Center's CanPrevent Program
PHILADELPHIA (September 15, 1999) -- Fox Chase Cancer Center's newest partner in the fight against prostate cancer is Educational Testing Service, headquartered in Princeton, N.J. Along with its subsidiary, the Chauncey Group International, ETS is offering its current and retired employees the latest in cancer education and screening through Fox Chase Cancer Center's CanPrevent: A Partnership at Work program. Spouses and domestic partners of current and retired employees may also participate.
Fox Chase began CanPrevent in 1997 as an outreach effort to promote the early detection and prevention of cancer by going to people where they work. Although workplace screening and wellness programs are increasingly popular, Fox Chase blends a unique combination of educational sessions, professional screening and follow-up, including referrals for high-risk people and ongoing communications.
The CanPrevent program at ETS will begin in early October with educational sessions about prostate cancer, the leading cause of cancer in the United States. One in six American men will develop prostate cancer, which is second only to lung cancer as the cause of cancer deaths among men in this country. Although the risk of this cancer increases after age 55, younger men can also develop the disease, especially if a close relative such as a father or brother has had the disease.
Dr. Mark J. Cornfeld of Princeton Junction, N.J., a Fox Chase medical oncologist and medical director of CanPrevent, will host the October education sessions and answer questions about prostate cancer. In addition to current and retired employees, their spouses and domestic partners may participate.
Free screening for prostate cancer will begin the day of the education session for eligible staff, retirees and spouses or domestic partners. Screening will be offered to men 50 and older and also to men 35 and older who have a family history of prostate cancer.
Screening participants will give a blood sample that Fox Chase will test for prostate-specific antigen (PSA). High PSA levels may indicate prostate enlargement or a cancerous tumor.
The second part of the screening, to be done during another visit to ETS, includes a physical examination-a digital rectal exam performed by Cornfeld. A Fox Chase case manager will go over the results of the blood test and physical exam with each screening participant, advising him whether he should make an appointment with a urologist. The case manager will also send results to the participant's primary-care physician.
ETS is the world's premier educational measurement institution and a leader in educational research.
Fox Chase Cancer Center is one of 36 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research, prevention, detection and treatment of cancer and community outreach programs.
For more information about Fox Chase Cancer Center's CanPrevent: A Partnership at Work, call 1-888-FOX CHASE (1-888-369-2427).
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.